Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels
Gloria E. Villalpando-Rodriguez(CancerCare Manitoba), Spencer B. Gibson(CancerCare Manitoba)
Cited by 76
Related Papers
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells
|Cell Death and Disease|2016|614
Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells
|PLoS ONE|2017|200
Functional LCK Is Required for Optimal CD28-mediated Activation of the TEC Family Tyrosine Kinase EMT/ITK
|Journal of Biological Chemistry|1996|76
Lysophosphatidic Acid Protects Cancer Cells from Histone Deacetylase (HDAC) Inhibitor-induced Apoptosis through Activation of HDAC
|Journal of Biological Chemistry|2008|38